Low Blood Content of IL-10-Producing CD4+ T Cells as a Risk Factor for Progression of Coronary Atherosclerosis
- Authors: Filatova A.Y.1, Pylaeva E.A.1, Potekhina A.V.1, Ruleva N.Y.1, Klesareva E.A.1, Radyukhina N.V.1, Masenko V.P.1, Shchinova A.M.1, Noeva E.A.1, Provatorov S.I.1, Afanas’eva O.I.1, Aref’eva T.I.1
-
Affiliations:
- Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
- Issue: Vol 166, No 3 (2019)
- Pages: 330-333
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/240999
- DOI: https://doi.org/10.1007/s10517-019-04344-z
- ID: 240999
Cite item
Abstract
In a 2-year prospective study, prognostic significance of the blood content of IL-10-producing CD4+ T lymphocytes for progression of coronary artery atherosclerosis was assessed. Patients with verified stable angina (n=36) admitted for scheduled coronary angiography and coronary stenting were enrolled. The blood levels of CD4+FoxpP3+ Treg, CD4+IFNγ+ Th1, CD4+IL17+ Th17, CD4+IL10+ cells, sCD25, IL-10, IL-17, C-reactive protein, and lipoprotein (a) were assayed before endovascular interventions. The blood content of CD4+IL10+ T cells below 3.3% was associated with progression of coronary artery atherosclerosis (OR 12.0 (2.3, 61.0), sensitivity 77%, specificity 78%, p=0.003). No differences in other immunological parameters and common atherosclerosis risk factors in the groups were revealed. We hypothesize that the content of CD4+IL10+ T cells can be an important predictive marker for the progression of coronary atherosclerosis.
About the authors
A. Yu. Filatova
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Author for correspondence.
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
E. A. Pylaeva
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
A. V. Potekhina
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
N. Yu. Ruleva
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
E. A. Klesareva
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
N. V. Radyukhina
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
V. P. Masenko
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
A. M. Shchinova
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
E. A. Noeva
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
S. I. Provatorov
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
O. I. Afanas’eva
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow
T. I. Aref’eva
Federal Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: anastasia.m088@yandex.ru
Russian Federation, Moscow